New Vaccine to Be Submitted for Regulatory Approval Based on Promising Study Results

February 24, 2022 by Alexa Hornbeck
<strong>New Vaccine to Be Submitted for Regulatory Approval Based on Promising Study Results</strong>

On Wednesday two companies, Sanofi and GlaxoSmithKline, said they plan to submit a new COVID-19 vaccine for U.S. and European regulatory approval. This followed Phase 3 efficacy trials that showed promise of protection both as a primary series and a booster shot. 

“No other global Phase 3 efficacy study has been undertaken during this period with so many variants of concern, including omicron,” said Thomas Triomphe, executive vice president of Sanofi Vaccines, in a written statement.

When used as a booster after a primary series of already authorized mRNA or adenovirus vaccines, the data from the Phase 3 trial showed the extra shot increased neutralizing antibodies by 18- to 30-fold across vaccine platforms and age groups.

The results showed the vaccine provided 100% protection against severe COVID-19 disease and hospitalizations, 75% efficacy against moderate to severe COVID-19 disease and 57.9% efficacy against symptomatic COVID-19 infection. 

When the vaccine was used as a two-dose primary series followed by a booster, the results showed that neutralizing antibodies increased 84- to 153-fold, compared to pre-boost levels. 

The early data also indicates a 77% efficacy against any delta variant-associated symptomatic COVID-19 disease. The vaccine also showed a favorable safety profile with both the primary series and booster vaccinations, especially for older adults.

The company had previously worked to make the vaccine available in the spring of 2020, but the lack of promising data led the companies to reformulate the vaccine to its current version.

The data suggests that the vaccine may provide stronger protection than the currently available Moderna or Pfizer vaccines. 

In summer 2021, Sanofi also partnered with BioNTech to provide large-scale manufacturing to support over 125 million doses of the COVID-19 vaccine for the European Union, demonstrating a shared commitment to increasing vaccine accessibility.

Alexa can be reached at [email protected]

A+
a-

In The News

Health

Voting

Health

Biden Announcing New Rule to Protect Consumers Who Purchase Short-Term Health Insurance Plans

President Joe Biden on Thursday announced new steps to protect consumers who buy short-term health insurance plans that critics say amount to junk. A... Read More

President Joe Biden on Thursday announced new steps to protect consumers who buy short-term health insurance plans that critics say amount to junk. A new rule finalized by the Democratic president's administration will limit these plans to just three months. And the plans can only be renewed for a maximum... Read More

March 27, 2024
by Dan McCue
One-Time Treatment Could Revitalize Immune Systems in the Elderly

PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of... Read More

PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of immune cell could potentially revitalize the immune systems of the elderly, helping their bodies better react to viral and bacterial threats. The research was carried out... Read More

March 27, 2024
by Dan McCue
Insurers to Expand Access to ‘Navigation Services’ for Cancer Patients

WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients... Read More

WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients and their families navigate the myriad challenges that might arise during treatment for cancer and other serious illnesses. The insurers involved are Aetna; Blue Cross Blue... Read More

Five Takeaways From the Abortion Pill Case Before US Supreme Court

WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone,... Read More

WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration. It's... Read More

Biden and Harris Argue Democrats Will Preserve Health Care and Republicans Would Take It Away

RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in... Read More

RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in the battleground state of North Carolina, arguing that Democrats like themselves would preserve access to care while Republicans would reverse gains made over the past decade... Read More

March 26, 2024
by Tom Ramstack
Supreme Court Skeptical of Ban on Abortion Pill Mifepristone

WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access... Read More

WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access to the abortion pill mifepristone despite objections from anti-abortion activists. The doctors and organizations who sued argued the Food and Drug Administration was wrong in granting... Read More

News From The Well
scroll top